SULINDAC IN OSTEOARTHROSIS OF THE HIP
- 1 May 1976
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 15 (2) , 112-115
- https://doi.org/10.1093/rheumatology/15.2.112
Abstract
Sulindac (400 mg/day) has been compared with ibuprofen (1200 mg/day) in 40 patients with osteoarthrosis of the hip, over an eight-week period, in a double-blind controlled clinical trial. The two drugs were comparable in terms of patient preference, effects on hip movements, and toxicity. Sulindac showed superior analgesic properties to ibuprofen, resulting in a significantly greater reduction in pain on weight-bearing and with passive movements P<0.01).Keywords
This publication has 0 references indexed in Scilit: